Stephen Hoge Moderna, Inc. (MRNA) insider trading activity

Stephen Hoge is President of Moderna, Inc.. Currently has a direct ownership of 1.45 Million shares of MRNA, which is worth approximately $38.9 Million. The most recent transaction as insider was on May 28, 2024, when has been sold 610 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.45M

0.47% 3M change

2.39% 12M change

Total Value Held $38.9 Million

Stephen Hoge Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 28 2024	BUY Exercise of conversion of derivative security	-	610 Added 0.04%	1,472,118 Common Stock
May 15 2024	SELL Open market or private sale	$1,912,350 $127.49 p/Share	15,000 Reduced 1.01%	1,471,508 Common Stock
May 10 2024	SELL Open market or private sale	$30,844 $120.96 p/Share	255 Reduced 0.02%	1,486,508 Common Stock
May 09 2024	BUY Exercise of conversion of derivative security	-	522 Added 0.04%	1,486,763 Common Stock
Apr 15 2024	SELL Open market or private sale	$1,575,300 $105.02 p/Share	15,000 Reduced 1.0%	1,486,241 Common Stock
Mar 15 2024	SELL Open market or private sale	$1,547,550 $103.17 p/Share	15,000 Reduced 0.99%	1,501,241 Common Stock
Mar 04 2024	SELL Open market or private sale	$29,151 $94.34 p/Share	309 Reduced 0.02%	1,516,241 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	-	652 Added 0.04%	1,516,550 Common Stock
Feb 29 2024	SELL Open market or private sale	$225,833 $94.57 p/Share	2,388 Reduced 0.16%	1,515,898 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	-	4,853 Added 0.32%	1,518,286 Common Stock
Feb 22 2024	SELL Open market or private sale	$1,500,000 $100.0 p/Share	15,000 Reduced 0.98%	1,513,433 Common Stock
Feb 16 2024	SELL Open market or private sale	$936,972 $88.88 p/Share	10,542 Reduced 0.69%	1,528,433 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	22,694 Added 1.45%	1,538,975 Common Stock
Feb 12 2024	SELL Open market or private sale	$26,213 $86.23 p/Share	304 Reduced 0.02%	1,516,281 Common Stock
Feb 09 2024	BUY Exercise of conversion of derivative security	-	522 Added 0.03%	1,516,585 Common Stock
Jan 16 2024	SELL Open market or private sale	$1,558,500 $103.9 p/Share	15,000 Reduced 0.98%	1,516,063 Common Stock
Dec 27 2023	SELL Open market or private sale	$4,500,450 $100.01 p/Share	45,000 Reduced 2.86%	1,531,063 Common Stock
Dec 04 2023	SELL Open market or private sale	$24,506 $79.31 p/Share	309 Reduced 0.02%	1,576,063 Common Stock
Dec 01 2023	BUY Exercise of conversion of derivative security	-	651 Added 0.04%	1,576,372 Common Stock
Nov 29 2023	SELL Open market or private sale	$90,664 $79.81 p/Share	1,136 Reduced 0.07%	1,575,721 Common Stock
Nov 28 2023	BUY Exercise of conversion of derivative security	-	2,411 Added 0.15%	1,576,857 Common Stock
Nov 10 2023	SELL Open market or private sale	$18,083 $68.76 p/Share	263 Reduced 0.02%	1,574,446 Common Stock
Nov 09 2023	BUY Exercise of conversion of derivative security	-	522 Added 0.03%	1,574,709 Common Stock
Sep 15 2023	SELL Open market or private sale	$1,694,850 $112.99 p/Share	15,000 Reduced 0.94%	1,574,187 Common Stock
Sep 05 2023	SELL Open market or private sale	$35,660 $111.44 p/Share	320 Reduced 0.02%	1,589,187 Common Stock

Also insider at

AXLA

Axcella Health Inc. Healthcare

Director

Stephen Hoge

President

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account